Roohani, S., Krcek, R., Mowery, Y. M., Ballman, K. V., Hong, A. M., Schuetze, S. M., … Kirsch, D. G. (2026). Tailoring Radiotherapy Margins in Primary Extremity Soft Tissue Sarcoma: Evidence for Safety and Efficacy from the Multicenter SU2C-SARC032 Trial. In ONCOLOGY RESEARCH AND TREATMENT (Vol. 49, pp. 167–167).

Roohani, Siyer, Reinhardt Krcek, Yvonne M. Mowery, Karla V. Ballman, Angela M. Hong, Scott M. Schuetze, Andrew J. Wagner, et al. “Tailoring Radiotherapy Margins in Primary Extremity Soft Tissue Sarcoma: Evidence for Safety and Efficacy from the Multicenter SU2C-SARC032 Trial.” In ONCOLOGY RESEARCH AND TREATMENT, 49:167–167, 2026.

Roohani S, Krcek R, Mowery YM, Ballman KV, Hong AM, Schuetze SM, et al. Tailoring Radiotherapy Margins in Primary Extremity Soft Tissue Sarcoma: Evidence for Safety and Efficacy from the Multicenter SU2C-SARC032 Trial. In: ONCOLOGY RESEARCH AND TREATMENT. 2026. p. 167–167.

Roohani, Siyer, et al. “Tailoring Radiotherapy Margins in Primary Extremity Soft Tissue Sarcoma: Evidence for Safety and Efficacy from the Multicenter SU2C-SARC032 Trial.” ONCOLOGY RESEARCH AND TREATMENT, vol. 49, 2026, pp. 167–167.

Roohani S, Krcek R, Mowery YM, Ballman KV, Hong AM, Schuetze SM, Wagner AJ, Monga V, Heise RS, Moding EJ, Weinhold KJ, van de Rijn M, Brigman BE, Riedel RF, Kirsch DG. Tailoring Radiotherapy Margins in Primary Extremity Soft Tissue Sarcoma: Evidence for Safety and Efficacy from the Multicenter SU2C-SARC032 Trial. ONCOLOGY RESEARCH AND TREATMENT. 2026. p. 167–167.